19 October 2026 Manager, Company Announcements ASX Limited Level 27 39 Martin Place SYDNEY NSW 2000 Via E-Lodgement 2026 Annual General Meeting Attached is the Mayne Pharma Group Limited 2026 Notice of Annual General Meeting and a related proxy form. A letter to shareholders from the...
2026 Notice of Annual General Meeting and shareholder pack
Filed with ASX · · 21 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Release
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- MYX settles US patent litigation re Imvexxy with Teva USA
- Supreme Court Decision in Cosette Proceedings
- Trading Halt
- Fulfilment of Imvexxy post-marketing study requirements
- Notification of cessation of securities - MYX
Later from Mayne Pharma
- Mayne Pharma reports unaudited Q1 FY27 results
- Investor presentation
- Notification regarding unquoted securities - MYX
- Mayne Pharma to divest International segment for $55.5m
- Investor presentation re International segment divestment
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma